279 filings
Page 7 of 14
S-8
agj3zn2uhb6
26 Feb 19
Registration of securities for employees
4:06pm
8-K
to0bexll732v
26 Feb 19
Epizyme Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results
6:34am
8-K
fyqc 7p5iw
17 Jan 19
Departure of Directors or Certain Officers
4:07pm
8-K
ha56ok2de yqq0ti74b
4 Jan 19
Epizyme Announces Registration Path for Tazemetostat for Follicular
6:39am
8-K
589z3xamhxj 02u5
15 Nov 18
Entry into a Material Definitive Agreement
6:36am
8-K
739k2
2 Nov 18
Epizyme Reports Third Quarter 2018 Financial Results and Tazemetostat Progress
6:30am
424B5
b2rhy3b di
3 Oct 18
Prospectus supplement for primary offering
4:49pm
8-K
j6gcaw
3 Oct 18
Entry into a Material Definitive Agreement
9:21am
424B5
yxykp jlla16yvp668l
2 Oct 18
Prospectus supplement for primary offering
4:41pm
8-K
chor60
17 Sep 18
Departure of Directors or Certain Officers
12:00am
8-K
78v4f6llnq1rik
5 Sep 18
Regulation FD Disclosure
12:00am
CT ORDER
kmm1r4
28 Aug 18
Confidential treatment order
12:00am
CT ORDER
01s4u8c gy
28 Aug 18
Confidential treatment order
12:00am
CT ORDER
t2n fj451547zwn
28 Aug 18
Confidential treatment order
12:00am
8-K
4t5b0ll3 rwv4b9fi6p
2 Aug 18
Epizyme Reports Second Quarter 2018 Financial Results and Provides Business Updates
8:52am
CT ORDER
44v1qay
5 Jun 18
Confidential treatment order
5:11pm
8-K
fwek j1udciew
21 May 18
Submission of Matters to a Vote of Security Holders
2:31pm